Merck & Co., Inc.
CIK: 0000310158SEC EDGAR →
Portfolio Value
$276.3M
Holdings
12
As of
Q4 2025
New Positions
12
Closed Positions
0
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | PERSONALIS INC | 14,044,943 | $111.8M | 40.47% |
| 2 | MODERNA INC | 2,308,190 | $68.1M | 24.64% |
| 3 | CARISMA THERAPEUTICS INC | 1,473,240 | $63.0M | 22.80% |
| 4 | KYMERA THERAPEUTICS INC | 772,165 | $60.1M | 21.75% |
| 5 | ENTRADA THERAPEUTICS INC | 1,739,768 | $17.9M | 6.47% |
| 6 | EVAXION BIOTECH A/S | 1,214,126 | $5.8M | 2.10% |
| 7 | ALECTOR INC | 3,545,719 | $5.5M | 2.00% |
| 8 | SUTRO BIOPHARMA INC | 272,351 | $3.2M | 1.14% |
| 9 | VIRIDIAN THERAPEUTICS INC | 93,414 | $2.9M | 1.05% |
| 10 | XILIO THERAPEUTICS INC | 1,483,758 | $949K | 0.34% |
Quarterly Changes
Top Buys
No buys this quarter
Top Sells
LAVA THERAPEUTICS NVCLOSED
$1.8M
STRO↓ Decreased
$786K
Closed Positions (1)
LAVA THERAPEUTICS NV
$1.8M · 1.1M shares
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 11 | $333.4M | 98.3% |
| Unknown | 1 | $5.8M | 1.7% |